Doxazosin
- Product NDC
- 66267-377
- 11-digit product format
- 662670377
- Labeler code
- 66267
- Product ID
- 66267-377_1fa6ba1c-3f81-2089-e063-6294a90a11c7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA202824
- Marketing category
- ANDA
- Marketing start
- 2015-04-22
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXAZOSIN MESYLATE | 4 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197627 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 66267-377-30 | Doxazosin | 30 in 1 BOTTLE | TABLET | 30 | | 6 |
| 66267-377-90 | Doxazosin | 90 in 1 BOTTLE | TABLET | 90 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 66267-377 | DOXAZOSIN TABLET [NUCARE PHARMACEUTICALS, INC.] | 6 | Current NDC, Legacy NDC, 2 package rows | 20240815_40e47e75-6a47-323b-e054-00144ff8d46c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 66267-377-30 | 66267037730 | 30 TABLET in 1 BOTTLE (66267-377-30) | 30 tablet | 2016-11-09 | 0000-00-00 | No | No | Current |
| 66267-377-90 | 66267037790 | 90 TABLET in 1 BOTTLE (66267-377-90) | 90 tablet | 2016-11-09 | 0000-00-00 | No | No | Current |